Sharon M Wolters, MD | |
1925 Woodwinds Dr, Woodbury, MN 55125-4445 | |
(651) 232-0228 | |
Not Available |
Full Name | Sharon M Wolters |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 29 Years |
Location | 1925 Woodwinds Dr, Woodbury, Minnesota |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336182955 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 49636 (Minnesota) | Primary |
207P00000X | Emergency Medicine | 25771 (Arizona) | Secondary |
207P00000X | Emergency Medicine | 53721 (Wisconsin) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Healtheast Woodwinds Hospital | Woodbury, MN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Healtheast Medical Research Institute | 3971407636 | 500 |
News Archive
The Food and Drug Administration (FDA) in the United States has given it's approval for the use of the drug Humira (adalimumab) to treat adults suffering from Crohn's disease.
President Barack Obama invited congressional leaders to meet with Vice President Joe Biden in hopes of taking on longer-term fiscal issues such as Medicare spending. Meanwhile, a new poll demonstrates that taking on such entitlement programs is challenging, because public opinion does not necessarily endorse deep cuts in this area.
The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.
UvA professors Cees Snoek and Marcel Worring are starting a new public-private research lab together with researchers from the Inception Institute of Artificial Intelligence Ltd. from the United Arab Emirates led by Professor Ling Shao.
› Verified 5 days ago
Entity Name | Fairview Health Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013994359 PECOS PAC ID: 1951213057 Enrollment ID: O20031105000461 |
News Archive
The Food and Drug Administration (FDA) in the United States has given it's approval for the use of the drug Humira (adalimumab) to treat adults suffering from Crohn's disease.
President Barack Obama invited congressional leaders to meet with Vice President Joe Biden in hopes of taking on longer-term fiscal issues such as Medicare spending. Meanwhile, a new poll demonstrates that taking on such entitlement programs is challenging, because public opinion does not necessarily endorse deep cuts in this area.
The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.
UvA professors Cees Snoek and Marcel Worring are starting a new public-private research lab together with researchers from the Inception Institute of Artificial Intelligence Ltd. from the United Arab Emirates led by Professor Ling Shao.
› Verified 5 days ago
Entity Name | Fairview Clinics |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346432218 PECOS PAC ID: 7113830142 Enrollment ID: O20031106000516 |
News Archive
The Food and Drug Administration (FDA) in the United States has given it's approval for the use of the drug Humira (adalimumab) to treat adults suffering from Crohn's disease.
President Barack Obama invited congressional leaders to meet with Vice President Joe Biden in hopes of taking on longer-term fiscal issues such as Medicare spending. Meanwhile, a new poll demonstrates that taking on such entitlement programs is challenging, because public opinion does not necessarily endorse deep cuts in this area.
The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.
UvA professors Cees Snoek and Marcel Worring are starting a new public-private research lab together with researchers from the Inception Institute of Artificial Intelligence Ltd. from the United Arab Emirates led by Professor Ling Shao.
› Verified 5 days ago
Entity Name | Healtheast Medical Research Institute |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1639125503 PECOS PAC ID: 3971407636 Enrollment ID: O20031124000507 |
News Archive
The Food and Drug Administration (FDA) in the United States has given it's approval for the use of the drug Humira (adalimumab) to treat adults suffering from Crohn's disease.
President Barack Obama invited congressional leaders to meet with Vice President Joe Biden in hopes of taking on longer-term fiscal issues such as Medicare spending. Meanwhile, a new poll demonstrates that taking on such entitlement programs is challenging, because public opinion does not necessarily endorse deep cuts in this area.
The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.
UvA professors Cees Snoek and Marcel Worring are starting a new public-private research lab together with researchers from the Inception Institute of Artificial Intelligence Ltd. from the United Arab Emirates led by Professor Ling Shao.
› Verified 5 days ago
Entity Name | Fairview Express Care |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1053952606 PECOS PAC ID: 3375645179 Enrollment ID: O20081028000548 |
News Archive
The Food and Drug Administration (FDA) in the United States has given it's approval for the use of the drug Humira (adalimumab) to treat adults suffering from Crohn's disease.
President Barack Obama invited congressional leaders to meet with Vice President Joe Biden in hopes of taking on longer-term fiscal issues such as Medicare spending. Meanwhile, a new poll demonstrates that taking on such entitlement programs is challenging, because public opinion does not necessarily endorse deep cuts in this area.
The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.
UvA professors Cees Snoek and Marcel Worring are starting a new public-private research lab together with researchers from the Inception Institute of Artificial Intelligence Ltd. from the United Arab Emirates led by Professor Ling Shao.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Sharon M Wolters, MD Po Box 218, 2600 65th Avenue, Osceola, WI 54020-3024 Ph: (715) 294-2111 | Sharon M Wolters, MD 1925 Woodwinds Dr, Woodbury, MN 55125-4445 Ph: (651) 232-0228 |
News Archive
The Food and Drug Administration (FDA) in the United States has given it's approval for the use of the drug Humira (adalimumab) to treat adults suffering from Crohn's disease.
President Barack Obama invited congressional leaders to meet with Vice President Joe Biden in hopes of taking on longer-term fiscal issues such as Medicare spending. Meanwhile, a new poll demonstrates that taking on such entitlement programs is challenging, because public opinion does not necessarily endorse deep cuts in this area.
The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.
UvA professors Cees Snoek and Marcel Worring are starting a new public-private research lab together with researchers from the Inception Institute of Artificial Intelligence Ltd. from the United Arab Emirates led by Professor Ling Shao.
› Verified 5 days ago
Dale J Meyer, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8450 Seasons Pkwy, Mail Stop 32900a, Woodbury, MN 55125 Phone: 651-702-5300 Fax: 651-702-5305 | |
Marisa Ann Spencer, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 237 Radio Dr Ste 210, Woodbury, MN 55125 Phone: 612-871-1145 Fax: 612-870-5491 | |
Rachel Elizabeth Kneeland, D.O. Internal Medicine Medicare: Medicare Enrolled Practice Location: 4040 Radio Dr, Woodbury, MN 55129 Phone: 651-439-8807 Fax: 651-439-0232 | |
Lisa C Ramsay, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 8675 Valley Creek Rd, Woodbury, MN 55125 Phone: 651-501-3028 Fax: 651-501-3049 | |
Dr. Ann Wendling, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6603 Crackleberry Trl, Woodbury, MN 55129 Phone: 651-459-3982 | |
Peter B Arnesen, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1925 Woodwinds Dr, Woodbury, MN 55125 Phone: 651-232-0100 | |
Sou-pan Wu, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4040 Radio Dr, Woodbury, MN 55129 Phone: 651-439-8807 Fax: 651-439-0232 |